Inhibitors of Akt activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S353000, C544S350000

Reexamination Certificate

active

11705677

ABSTRACT:
The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention

REFERENCES:
patent: 5932580 (1999-08-01), Levitzki et al.
patent: 5972937 (1999-10-01), Gaster et al.
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 2002/0127214 (2002-09-01), Hemmings
patent: 2006/0142178 (2006-06-01), Barnett et al.
patent: WO 96/23783 (1996-08-01), None
patent: WO 97/22360 (1997-06-01), None
patent: WO 99/42461 (1999-06-01), None
patent: WO 01/91754 (2001-12-01), None
patent: WO 02/083138 (2002-10-01), None
patent: WO 03/084473 (2003-10-01), None
Nakatani, et al., J. Bio. Chem., vol. 274, pp. 21528-21535 (1999).
Bellacosa, et al., Intl. J. Cancer, vol. 64, pp. 280-285 (1995).
Hanada, et al., Biochimica et Biophysica Acta, vol. 1697, pp. 3-16 (2004).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitors of Akt activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of Akt activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of Akt activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3927597

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.